Target intelligence / Profile preview

MYCBP2 antisense RNA 2 (MYCBP2-AS2)

Target
MYCBP2-AS2
Molecular classification
Other (long non-coding RNA / antisense RNA)
01

Overview

MYCBP2 antisense RNA 2 (MYCBP2-AS2) is a non-protein coding antisense transcript overlapping the MYCBP2 gene locus. These RNAs are often transcribed in the opposite direction to their protein-coding partners and may regulate gene expression through mechanisms such as transcriptional interference, RNA-RNA interaction, or chromatin modification. However, there are no published studies specifically describing the biological function, disease relevance, or therapeutic targeting of MYCBP2-AS2. Most available scientific and clinical data are limited to the protein-coding MYCBP2 gene. Important Clarification: Much of the published research and functional annotation in public databases (GeneCards, PubMed) referenced for "MYCBP2 antisense RNA 2" instead describes the protein-coding MYCBP2 (Myc binding protein 2), which is an atypical E3 ubiquitin ligase with key roles in neuronal development, synaptic growth, and cancer biology. MYCBP2 itself is considered a potential molecular target, but this is NOT true for MYCBP2-AS2. Conclusion: MYCBP2-AS2 is a long non-coding antisense RNA without direct evidence of biological function, disease relevance, or therapeutic targeting. The essential information found in public databases conflates MYCBP2-AS2 with the protein-coding MYCBP2 gene. Any structured annotation should treat MYCBP2-AS2 separately and not inherit molecular function, disease, or drug data from MYCBP2.

Other names
MYCBP2 antisense RNA 2MYCBP2-AS2MYCBP2 antisense RNA 2 (non-protein coding)
02

Mechanism of action

None known (no known mechanism described for this RNA as a target)

03

Biological functions

Unknown (no published functional annotation for MYCBP2-AS2 itself; distinct from MYCBP2 protein’s known roles in axon guidance and synaptogenesis)
04

Disease associations

Unknown (no published disease association for MYCBP2-AS2 itself; most disease evidence relates to MYCBP2 protein)

Beyond the preview

Go deeper on MYCBP2 antisense RNA 2 (MYCBP2-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MYCBP2 antisense RNA 2 (MYCBP2-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call